Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

February 25, 2014
Otsuka Pharmaceutical

Otsuka's Antipsychotic Aripiprazole Awarded the 60th Okochi Memorial Prize
February 24, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports the Tokyo Marathon 2014 Runners With Amino Value, the Official Beverage
February 24, 2014
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory announces HINE E-GEL concentrated liquid nutrition product launched on February 24, 2014
February 17, 2014
Otsuka Pharmaceutical

Meptin Swinghaler, Easy-to-inhale Bronchodilator for COPD and Asthma Patients, Approved in Japan
February 13, 2014
Otsuka Pharmaceutical

Otsuka and Lundbeck Announce Once-Monthly Abilify Maintena™ Approved in Canada for the Maintenance Treatment of Schizophrenia in Stabilized Adult Patients
January 27, 2014
Otsuka Holdings

Otsuka announces 2013 fourth quarter U.S. net sales figures of ABILIFY®
January 24, 2014
Otsuka Holdings

Otsuka and Lundbeck to present new data on brexpiprazole in major depressive disorder (MDD) at European Psychiatry Association 2014 Congress
January 24, 2014
Otsuka Pharmaceutical

Otsuka and Lundbeck to present new data on brexpiprazole in major depressive disorder (MDD) at European Psychiatry Association 2014 Congress
January 20, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical's POCARI SWEAT to Be Official Drink for Two Consecutive Asian Games
January 15, 2014
Otsuka Holdings

Otsuka Pharmaceutical Submits Marketing Authorization Application in Japanz for Abilify Once-Monthly Injectable Form for the Treatment of Schizophrenia
January 15, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Submits Marketing Authorization Application in Japan for Abilify Once-Monthly Injectable Form for the Treatment of Schizophrenia
January 6, 2014
Taiho Pharmaceutical

Transfer of Astellas’ Fermentation Research-Related Assets to Taiho Pharmaceutical